Trial Profile
Designated Drug Use Investigation 1 of Follistim Injection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2022
Price :
$35
*
At a glance
- Drugs Follitropin beta (Primary) ; Follitropin beta (Primary)
- Indications Infertility
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.; Organon; Schering-Plough
- 07 Oct 2009 Trial sponsor changed from 'Organon' to 'Schering-Plough' as reported by ClinicalTrials.gov.
- 23 Jun 2009 New trial record